GroundRules
Browse Federal regulations
Read the original sections, or search by topic.
- 21 CFR 660.30 · Reagent Red Blood Cells.
- 21 CFR 660.31 · Eligibility of donor.
- 21 CFR 660.32 · Collection of source material.
- 21 CFR 660.33 · Testing of source material.
- 21 CFR 660.34 · Processing.
- 21 CFR 660.35 · Labeling.
- 21 CFR 660.36 · Samples and protocols.
- 21 CFR 660.40 · Hepatitis B Surface Antigen.
- 21 CFR 660.41 · Processing.
- 21 CFR 660.43 · Potency test.
- 21 CFR 660.44 · Specificity.
- 21 CFR 660.45 · Labeling.
- 21 CFR 660.46 · Samples; protocols; official release.
- 21 CFR 660.50 · Anti-Human Globulin.
- 21 CFR 660.51 · Processing.
- 21 CFR 660.52 · Reference preparations.
- 21 CFR 660.53 · Controls for serological procedures.
- 21 CFR 660.54 · Potency tests, specificity tests, tests for heterospecific antibodies, and additional tests for nonspecific properties.
- 21 CFR 660.55 · Labeling.
- 21 CFR 680.1 · Allergenic Products.
- 21 CFR 680.2 · Manufacture of Allergenic Products.
- 21 CFR 680.3 · Tests.
- 21 CFR 700.3 · Definitions.
- 21 CFR 700.11 · Cosmetics containing bithionol.
- 21 CFR 700.13 · Use of mercury compounds in cosmetics including use as skinbleaching agents in cosmetic preparations also regarded as drugs.
- 21 CFR 700.14 · Use of vinyl chloride as an ingredient, including propellant of cosmetic aerosol products.
- 21 CFR 700.15 · Use of certain halogenated salicylanilides as ingredients in cosmetic products.
- 21 CFR 700.16 · Use of aerosol cosmetic products containing zirconium.
- 21 CFR 700.18 · Use of chloroform as an ingredient in cosmetic products.
- 21 CFR 700.19 · Use of methylene chloride as an ingredient of cosmetic products.
- 21 CFR 700.23 · Chlorofluorocarbon propellants.
- 21 CFR 700.25 · Tamper-resistant packaging requirements for cosmetic products.
- 21 CFR 700.27 · Use of prohibited cattle materials in cosmetic products.
- 21 CFR 700.35 · Cosmetics containing sunscreen ingredients.
- 21 CFR 701.1 · Misbranding.
- 21 CFR 701.2 · Form of stating labeling requirements.
- 21 CFR 701.3 · Designation of ingredients.
- 21 CFR 701.9 · Exemptions from labeling requirements.
- 21 CFR 701.10 · Principal display panel.
- 21 CFR 701.11 · Identity labeling.
- 21 CFR 701.12 · Name and place of business of manufacturer, packer, or distributor.
- 21 CFR 701.13 · Declaration of net quantity of contents.
- 21 CFR 701.20 · Detergent substances, other than soap, intended for use in cleansing the body.
- 21 CFR 701.30 · Ingredient names established for cosmetic ingredient labeling.
- 21 CFR 710.1 · Who should register.
- 21 CFR 710.2 · Time for registration.
- 21 CFR 710.3 · How and where to register.
- 21 CFR 710.4 · Information requested.
- 21 CFR 710.5 · Amendments to registration.
- 21 CFR 710.6 · Notification of registrant; cosmetic product establishment registration number.
- 21 CFR 710.7 · Inspection of registrations.
- 21 CFR 710.8 · Misbranding by reference to registration or to registration number.
- 21 CFR 710.9 · Exemptions.
- 21 CFR 720.1 · Who should file.
- 21 CFR 720.2 · Times for filing.
- 21 CFR 720.3 · How and where to file.
- 21 CFR 720.4 · Information requested about cosmetic products.
- 21 CFR 720.5 · [Reserved]
- 21 CFR 720.6 · Amendments to statement.
- 21 CFR 720.7 · Notification of person submitting cosmetic product ingredient statement.
- 21 CFR 720.8 · Confidentiality of statements.
- 21 CFR 720.9 · Misbranding by reference to filing or to statement number.
- 21 CFR 740.1 · Establishment of warning statements.
- 21 CFR 740.2 · Conspicuousness of warning statements.
- 21 CFR 740.10 · Labeling of cosmetic products for which adequate substantiation of safety has not been obtained.
- 21 CFR 740.11 · Cosmetics in self-pressurized containers.
- 21 CFR 740.12 · Feminine deodorant sprays.
- 21 CFR 740.17 · Foaming detergent bath products.
- 21 CFR 740.18 · Coal tar hair dyes posing a risk of cancer.
- 21 CFR 740.19 · Suntanning preparations.
- 21 CFR 800.10 · Contact lens solutions; sterility.
- 21 CFR 800.12 · Contact lens solutions and tablets; tamper-resistant packaging.
- 21 CFR 800.20 · Patient examination gloves and surgeons' gloves; sample plans and test method for leakage defects; adulteration.
- 21 CFR 800.30 · Over-the-counter hearing aid controls.
- 21 CFR 800.55 · Administrative detention.
- 21 CFR 800.75 · Requests for supervisory review of certain decisions made by the Center for Devices and Radiological Health.
- 21 CFR 801.1 · Medical devices; name and place of business of manufacturer, packer or distributor.
- 21 CFR 801.3 · Definitions.
- 21 CFR 801.4 · Meaning of intended uses.
- 21 CFR 801.5 · Medical devices; adequate directions for use.
- 21 CFR 801.6 · Medical devices; misleading statements.
- 21 CFR 801.15 · Medical devices; prominence of required label statements; use of symbols in labeling.
- 21 CFR 801.16 · Medical devices; Spanish-language version of certain required statements.
- 21 CFR 801.18 · Format of dates provided on a medical device label.
- 21 CFR 801.20 · Label to bear a unique device identifier.
- 21 CFR 801.30 · General exceptions from the requirement for the label of a device to bear a unique device identifier.
- 21 CFR 801.35 · Voluntary labeling of a device with a unique device identifier.
- 21 CFR 801.40 · Form of a unique device identifier.
- 21 CFR 801.45 · Devices that must be directly marked with a unique device identifier.
- 21 CFR 801.50 · Labeling requirements for stand-alone software.
- 21 CFR 801.55 · Request for an exception from or alternative to a unique device identifier requirement.
- 21 CFR 801.57 · Discontinuation of legacy FDA identification numbers assigned to devices.
- 21 CFR 801.60 · Principal display panel.
- 21 CFR 801.61 · Statement of identity.
- 21 CFR 801.62 · Declaration of net quantity of contents.
- 21 CFR 801.63 · Medical devices; warning statements for devices containing or manufactured with chlorofluorocarbons and other class I ozone-depleting substances.
- 21 CFR 801.109 · Prescription devices.
- 21 CFR 801.110 · Retail exemption for prescription devices.
- 21 CFR 801.116 · Medical devices having commonly known directions.
- 21 CFR 801.119 · In vitro diagnostic products.